Literature DB >> 21659431

Pain is a common problem affecting clinical outcomes in adults with cystic fibrosis.

Margaret Hayes1, Myron Yaster2, Jennifer A Haythornthwaite3, Kristin A Riekert4, Kristen Nelson McMillan2, Elizabeth White2, Peter J Mogayzel5, Noah Lechtzin6.   

Abstract

BACKGROUND: As the cystic fibrosis (CF) population has aged, many chronic health problems have emerged, including diabetes mellitus and osteoporosis. Previous studies have suggested that pain is common in patients with CF; however, little is known about the factors associated with it or its impact on clinical outcomes. We hypothesized that pain is common, is associated with psychologic distress, and adversely affects clinical outcomes.
METHODS: From February 1, 2008, to April 3, 2008, adults with CF from Johns Hopkins Hospital were surveyed about their pain. Outcomes were assessed for 12 months following survey completion. Bivariate analyses were performed using Wilcoxon log rank, Kruskal-Wallis tests, and Spearman correlations. Logistic regression models and Cox proportional hazard models were used to analyze clinical outcomes.
RESULTS: Eighty-three patients (61%) completed the survey. Eighty-two percent of patients reported pain within the past month, the most common sites being the head, sinuses, back, and chest. Pain frequently interfered with general activities (41.9%), mood (56.8%), and work (47.3%). Symptoms of depression and anxiety, as well as lower quality-of-life (QOL) scores, were associated with the presence of pain (P < .05 for each). The risk of pulmonary exacerbations was increased in patients with higher levels of pain, even after adjusting for FEV(1) and age (OR = 1.65; P = .038; 95% CI, 1.03-2.64). Additionally, the risk of death was higher in patients with higher average pain scores (HR = 2.28; P = .008; 95% CI = 1.2-4.2).
CONCLUSIONS: Pain is common in adults with CF, interferes with activities, and is associated with lower QOL and an increased risk of both exacerbations and death.

Entities:  

Mesh:

Year:  2011        PMID: 21659431     DOI: 10.1378/chest.11-0132

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  11 in total

1.  Palliative care for patients with cystic fibrosis #265.

Authors:  Juvianee Estrada-Veras; Hunter Groninger
Journal:  J Palliat Med       Date:  2013-02-26       Impact factor: 2.947

Review 2.  Pain and its clinical associations in individuals with cystic fibrosis: A systematic review.

Authors:  Annemarie L Lee; Sarah Rawlings; Katharine A Bennett; David Armstrong
Journal:  Chron Respir Dis       Date:  2016-02-12       Impact factor: 2.444

Review 3.  Bisphosphonates for osteoporosis in people with cystic fibrosis.

Authors:  Louise S Conwell; Anne B Chang
Journal:  Cochrane Database Syst Rev       Date:  2014-03-14

4.  Vitamin D Deficiency and Pain: Clinical Evidence of Low Levels of Vitamin D and Supplementation in Chronic Pain States.

Authors:  Elspeth E Shipton; Edward A Shipton
Journal:  Pain Ther       Date:  2015-04-29

Review 5.  Vitamin D and Pain: Vitamin D and Its Role in the Aetiology and Maintenance of Chronic Pain States and Associated Comorbidities.

Authors:  Edward A Shipton; Elspeth E Shipton
Journal:  Pain Res Treat       Date:  2015-04-19

6.  Impact of osteopathic treatment on pain in adult patients with cystic fibrosis--a pilot randomized controlled study.

Authors:  Dominique Hubert; Lucile Soubeiran; Fabrice Gourmelon; Dominique Grenet; Raphaël Serreau; Elodie Perrodeau; Rafael Zegarra-Parodi; Isabelle Boutron
Journal:  PLoS One       Date:  2014-07-16       Impact factor: 3.240

7.  Physiotherapy for cystic fibrosis in Australia and New Zealand: A clinical practice guideline.

Authors:  Brenda M Button; Christine Wilson; Ruth Dentice; Narelle S Cox; Anna Middleton; Esta Tannenbaum; Jennifer Bishop; Robyn Cobb; Kate Burton; Michelle Wood; Fiona Moran; Ryan Black; Summar Bowen; Rosemary Day; Julie Depiazzi; Katherine Doiron; Michael Doumit; Tiffany Dwyer; Alison Elliot; Louise Fuller; Kathleen Hall; Matthew Hutchins; Melinda Kerr; Annemarie L Lee; Christina Mans; Lauren O'Connor; Ranjana Steward; Angela Potter; Tshepo Rasekaba; Rebecca Scoones; Ben Tarrant; Nathan Ward; Samantha West; Dianne White; Lisa Wilson; Jamie Wood; Anne E Holland
Journal:  Respirology       Date:  2016-04-18       Impact factor: 6.424

8.  Prospective multicenter randomized patient recruitment and sample collection to enable future measurements of sputum biomarkers of inflammation in an observational study of cystic fibrosis.

Authors:  Theodore G Liou; Frederick R Adler; Natalia Argel; Fadi Asfour; Perry S Brown; Barbara A Chatfield; Cori L Daines; Dixie Durham; Jessica A Francis; Barbara Glover; Theresa Heynekamp; John R Hoidal; Judy L Jensen; Ruth Keogh; Carol M Kopecky; Noah Lechtzin; Yanping Li; Jerimiah Lysinger; Osmara Molina; Craig Nakamura; Kristyn A Packer; Katie R Poch; Alexandra L Quittner; Peggy Radford; Abby J Redway; Scott D Sagel; Shawna Sprandel; Jennifer L Taylor-Cousar; Jane B Vroom; Ryan Yoshikawa; John P Clancy; J Stuart Elborn; Kenneth N Olivier; David R Cox
Journal:  BMC Med Res Methodol       Date:  2019-04-26       Impact factor: 4.615

9.  Patient-reported outcomes in patients with cystic fibrosis with a G551D mutation on ivacaftor treatment: results from a cross-sectional study.

Authors:  Scott C Bell; Jochen G Mainz; Gordon MacGregor; Susan Madge; Julie Macey; Moshe Fridman; Ellison D Suthoff; Siva Narayanan; Nils Kinnman
Journal:  BMC Pulm Med       Date:  2019-08-13       Impact factor: 3.317

10.  Satisfaction and effectiveness of opioid pain management among adults with cystic fibrosis: A mixed methods study.

Authors:  Sarah Allgood; Jessica L Zemlak; Elisabeth Dellon; Siddhartha G Kapnadak; Jessica Goggin; Noah Lechtzin
Journal:  J Cyst Fibros       Date:  2021-07-10       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.